Heparan Sulfate Glycosaminoglycans: (Un)Expected Allies in Cancer Clinical Management
In an era when cancer glycobiology research is exponentially growing, we are witnessing a progressive translation of the major scientific findings to the clinical practice with the overarching aim of improving cancer patients’ management. Many mechanistic cell biology studies have demonstrated that...
Main Authors: | Isabel Faria-Ramos, Juliana Poças, Catarina Marques, João Santos-Antunes, Guilherme Macedo, Celso A. Reis, Ana Magalhães |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/11/2/136 |
Similar Items
-
Heparan Sulfate Biosynthesis and Sulfation Profiles as Modulators of Cancer Signalling and Progression
by: Catarina Marques, et al.
Published: (2021-11-01) -
Heparan Sulfate: A Ubiquitous Glycosaminoglycan with Multiple Roles in Immunity
by: David Anak Simon Davis, et al.
Published: (2013-12-01) -
Dexamethasone Inhibits Heparan Sulfate Biosynthetic System and Decreases Heparan Sulfate Content in Orthotopic Glioblastoma Tumors in Mice
by: Dmitry K. Sokolov, et al.
Published: (2023-06-01) -
Coxsackievirus A16 utilizes cell surface heparan sulfate glycosaminoglycans as its attachment receptor
by: Xueyang Zhang, et al.
Published: (2017-01-01) -
The heparan sulfate and its diverse biological activities
by: Kaznowska-Bystryk Iwona
Published: (2014-12-01)